242 related articles for article (PubMed ID: 11737617)
1. A randomized trial of iron deficiency testing strategies in hemodialysis patients.
Fishbane S; Shapiro W; Dutka P; Valenzuela OF; Faubert J
Kidney Int; 2001 Dec; 60(6):2406-11. PubMed ID: 11737617
[TBL] [Abstract][Full Text] [Related]
2. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
[TBL] [Abstract][Full Text] [Related]
3. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.
Kaneko Y; Miyazaki S; Hirasawa Y; Gejyo F; Suzuki M
Kidney Int; 2003 Mar; 63(3):1086-93. PubMed ID: 12631092
[TBL] [Abstract][Full Text] [Related]
4. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
5. Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content.
Mitsuiki K; Harada A; Miyata Y
Clin Exp Nephrol; 2003 Mar; 7(1):52-7. PubMed ID: 14586744
[TBL] [Abstract][Full Text] [Related]
6. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
Coyne DW; Kapoian T; Suki W; Singh AK; Moran JE; Dahl NV; Rizkala AR;
J Am Soc Nephrol; 2007 Mar; 18(3):975-84. PubMed ID: 17267740
[TBL] [Abstract][Full Text] [Related]
7. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
8. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF
Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
[TBL] [Abstract][Full Text] [Related]
9. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of iron indices in hemodialysis patients receiving epoetin.
Kaufman JS; Reda DJ; Fye CL; Goldfarb DS; Henderson WG; Kleinman JG; Vaamonde CA;
Kidney Int; 2001 Jul; 60(1):300-8. PubMed ID: 11422765
[TBL] [Abstract][Full Text] [Related]
11. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients.
Tsuchiya K; Okano H; Teramura M; Iwamoto Y; Yamashita N; Suda A; Shimada K; Nihei H; Ando M
Clin Nephrol; 2003 Feb; 59(2):115-23. PubMed ID: 12608554
[TBL] [Abstract][Full Text] [Related]
12. Reticulocyte hemoglobin content in hemodialysis patients with acute infection.
Mitsuiki K; Harada A; Miyata Y
Clin Exp Nephrol; 2004 Sep; 8(3):257-62. PubMed ID: 15480904
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.
Fishbane S; Lynn RI
Clin Nephrol; 1995 Oct; 44(4):238-40. PubMed ID: 8575123
[TBL] [Abstract][Full Text] [Related]
14. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients.
Fishbane S; Galgano C; Langley RC; Canfield W; Maesaka JK
Kidney Int; 1997 Jul; 52(1):217-22. PubMed ID: 9211366
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and specificity of transferrin saturation and serum ferritin as markers of iron status after intravenous iron dextran in hemodialysis patients.
Low CL; Bailie GR; Eisele G
Ren Fail; 1997 Nov; 19(6):781-8. PubMed ID: 9415935
[TBL] [Abstract][Full Text] [Related]
16. The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.
Pollak VE; Lorch JA; Shukla R; Satwah S
BMC Nephrol; 2009 Feb; 10():6. PubMed ID: 19245700
[TBL] [Abstract][Full Text] [Related]
17. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients.
Besarab A; Amin N; Ahsan M; Vogel SE; Zazuwa G; Frinak S; Zazra JJ; Anandan JV; Gupta A
J Am Soc Nephrol; 2000 Mar; 11(3):530-538. PubMed ID: 10703677
[TBL] [Abstract][Full Text] [Related]
18. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.
Ogawa C; Tsuchiya K; Tomosugi N; Kanda F; Maeda K; Maeda T
PLoS One; 2017; 12(6):e0179608. PubMed ID: 28662118
[TBL] [Abstract][Full Text] [Related]
19. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
Fishbane S; Frei GL; Maesaka J
Am J Kidney Dis; 1995 Jul; 26(1):41-6. PubMed ID: 7611266
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
